Agilent Technologies (NYSE:A) Price Target Raised to $190.00

Agilent Technologies (NYSE:A) had its price objective hoisted by Citigroup from $185.00 to $190.00 in a report issued on Thursday,Benzinga reports. Citigroup currently has a buy rating on the medical research company’s stock.

Several other brokerages also recently commented on A. Piper Sandler initiated coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. HSBC reduced their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Royal Bank Of Canada lifted their price target on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday. Finally, Wells Fargo & Company reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies Price Performance

NYSE:A opened at $154.47 on Thursday. Agilent Technologies has a 12-month low of $108.35 and a 12-month high of $163.75. The firm has a market capitalization of $43.63 billion, a price-to-earnings ratio of 30.41, a P/E/G ratio of 2.65 and a beta of 1.25. The stock’s 50 day moving average price is $140.30 and its two-hundred day moving average price is $127.04. The company has a quick ratio of 1.62, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the company posted $1.37 EPS. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts anticipate that Agilent Technologies will post 6.2 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of A. Corient Private Wealth LP raised its stake in Agilent Technologies by 8.5% in the second quarter. Corient Private Wealth LP now owns 240,532 shares of the medical research company’s stock valued at $31,952,000 after purchasing an additional 18,901 shares in the last quarter. Amundi increased its holdings in Agilent Technologies by 20.3% in the 2nd quarter. Amundi now owns 1,294,098 shares of the medical research company’s stock valued at $171,891,000 after buying an additional 218,514 shares during the period. HighTower Advisors LLC raised its position in shares of Agilent Technologies by 3.3% in the 2nd quarter. HighTower Advisors LLC now owns 176,828 shares of the medical research company’s stock valued at $23,488,000 after buying an additional 5,710 shares in the last quarter. California State Teachers Retirement System increased its stake in Agilent Technologies by 12,343.3% in the second quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company’s stock valued at $7,249,471,000 after acquiring an additional 54,138,451 shares during the last quarter. Finally, Wedmont Private Capital raised its position in Agilent Technologies by 10.8% during the second quarter. Wedmont Private Capital now owns 5,599 shares of the medical research company’s stock valued at $752,000 after purchasing an additional 547 shares in the last quarter.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.